Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Trodelvy Gets Accelerated Approval for Urothelial Cancer
Why Racial and Ethnic Disparities Exist in Kidney Disease Care
Vadadustat NDA Submitted for Anemia Due to Chronic Kidney Disease
FDA-Approved VEGFR Tyrosine Kinase Inhibitors Ranked by Cardiotoxic Potential
Fotivda Now Available for Renal Cell Carcinoma
Albuminuria Reduction Greater With SGLT2 Inhibitor, ERA Combo
Belzutifan Gets Priority Review for Von Hippel-Lindau Disease-Associated RCC
Improved Overall Survival With Cemiplimab in Cervical Cancer Trial
Nicotinamide May Improve Phosphate Control in Hemodialysis Patients
Fotivda Approved for Relapsed/Refractory Advanced Renal Cell Carcinoma
NSAID May Increase AKI Risk in Hospitalized Children
Tecentriq Indication for Prior-Platinum Treated Bladder Cancer Withdrawn
Jury Penalizes Physician for Failing to Follow Up on Abnormal Urinalysis
Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome
FDA to Review Difelikefalin for Chronic Kidney Disease-Associated Pruritus
KDIGO Updates Blood Pressure Guideline for Nondialysis CKD
Hyperkalemia Due to RAAS Inhibitors Best Treated by Stopping the Drugs
Conservative CKD-MBD Management at Dialysis Initiation on the Rise
